Join
Live feed
·
INSIDERFilingvia Quantisnow
Cellectar Biosciences Inc. logo

Chief Executive Officer Caruso James V bought $24,998 worth of shares (8,680 units at $2.88), increasing direct ownership by 75% to 20,318 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CLRB· Cellectar Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLRB (Cellectar Biosciences Inc.) and more on Quantisnow.